Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?
To establish whether women over 65 years of age with newly diagnosed with breast cancer (BC) receive adjuvant chemotherapy less frequently than younger postmenopausal women and whether comorbidity influences this potential undertreatment.
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
27 June 2016
|
| In: |
Journal of cancer research and clinical oncology
Year: 2016, Volume: 142, Issue: 8, Pages: 1847-1853 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-016-2194-4 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00432-016-2194-4 |
| Author Notes: | C. W. Wallwiener, A. D. Hartkopf, E. Grabe, M. Wallwiener, F.-A. Taran, T. Fehm, S. Y. Brucker, B. Krämer |
| Summary: | To establish whether women over 65 years of age with newly diagnosed with breast cancer (BC) receive adjuvant chemotherapy less frequently than younger postmenopausal women and whether comorbidity influences this potential undertreatment. |
|---|---|
| Item Description: | Gesehen am 05.06.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-016-2194-4 |